Anthem, Cigna merger squabbles could delay antitrust approval: WSJ May 22, 2016 01:54PM
Notable Analyst Rating Changes 2/2: PFE, ESRX, CLX, AKAM Upgraded; F, NYX, ETFC, WU Downgraded Feb 2, 2009 09:52AM
Notable Analyst Rating Changes 8/4: CX, NEU, CHK, AKAM Upgraded; DE, AKS, ESRX, ELN Downgraded Aug 4, 2008 10:10AM